FDA Inspection 1211584 — AstraZeneca Pharmaceuticals, LP
The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on Jul 19, 2023 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 19, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Newark, DE (United States)